Hatakeyama Hiromitsu, Kondo Tadashi, Fujii Kiyonaga, Nakanishi Yukihiro, Kato Hoichi, Fukuda Satoshi, Hirohashi Setsuo
Proteome Bioinformatics Project, National Cancer Center Research Institute, Tokyo, Japan.
Proteomics. 2006 Dec;6(23):6300-16. doi: 10.1002/pmic.200600488.
We examined the proteomic background of esophageal cancer. We used laser microdissection to obtain tumor tissues from 72 esophageal squamous cell carcinoma cases and adjacent normal tissues in 57 of these cases. The 2D-DIGE generated quantitative expression profiles with 1730 protein spots. Based on the intensity of the protein spots, unsupervised classification distinguished the tumor tissues from their normal counterparts, and subdivided the tumor tissues according to their histological differentiation. We identified 498 protein spots with altered intensity in the tumor tissues, which protein identification by LC-MS/MS showed to correspond to 217 gene products. We also found 41 protein spots that were associated with nodal metastasis, and identified 33 proteins corresponding to the spots, including cancer-associated proteins such as alpha-actinin 4, hnRNP K, periplakin, squamous cell carcinoma antigen 1 and NudC. The identified cancer-associated proteins have been previously reported to be individually involved in a range of cancer types, and our study observed them collectively in a single type of malignancy, esophageal cancer. As the identified proteins are involved in important biological processes such as cytoskeletal/structural organization, transportation, chaperon, oxidoreduction, transcription and signal transduction, they may function in a coordinate manner in carcinogenesis and tumor progression of esophageal cancer.
我们研究了食管癌的蛋白质组学背景。我们使用激光显微切割技术从72例食管鳞状细胞癌病例中获取肿瘤组织,并从其中57例病例中获取相邻的正常组织。二维差异凝胶电泳(2D-DIGE)生成了具有1730个蛋白质点的定量表达谱。基于蛋白质点的强度,无监督分类将肿瘤组织与其正常对应物区分开来,并根据组织学分化对肿瘤组织进行细分。我们在肿瘤组织中鉴定出498个强度改变的蛋白质点,通过液相色谱-串联质谱(LC-MS/MS)进行蛋白质鉴定显示这些点对应于217个基因产物。我们还发现41个与淋巴结转移相关的蛋白质点,并鉴定出与这些点对应的33种蛋白质,包括与癌症相关的蛋白质,如α-辅肌动蛋白4、异质性核糖核蛋白K、周膜蛋白、鳞状细胞癌抗原1和NudC。先前已有报道称,所鉴定出的这些与癌症相关的蛋白质分别参与多种癌症类型,而我们的研究在单一类型的恶性肿瘤——食管癌中共同观察到了它们。由于所鉴定出的蛋白质参与细胞骨架/结构组织、运输、伴侣蛋白、氧化还原、转录和信号转导等重要生物学过程,它们可能在食管癌的致癌作用和肿瘤进展中以协同方式发挥作用。